Related Experiment Video
Updated: Apr 27, 2026

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
[MicroRNA and hypertension]
Abstract:
MicroRNA(miRNA) is involved in virtually all biologic processes, including cellular proliferation, apoptosis, and differentiation. Thus, miRNA deregulation often results in impaired cellular function and disease development, so miRNAs have potential therapeutic relevance. The elucidation of these processes regulated by miRNAs and the identification of novel miRNA targets in the pathogenesis of hypertension is a highly valuable and exciting strategy that may eventually led to the development of novel treatment approaches for hypertension. Several mechanisms have been implicated in the pathogenesis of hypertension: overactivation of therenin-angiotensin-aldosterone system (RAAS), dysfunction of the vascular endothelium, damnification of vascular smooth muscle. To maintain and restore target organ expression of miRNA stable may be a new strategy for treatment of hypertension. The article reviews pathogenesis of miRNA and hypertension, researches of miRNAs as biomarker and therapeutic target, discusses advances in miRNA-based approaches that may be important in treating hypertension.
Insights
MicroRNAs (miRNAs) regulate cellular processes, and their dysregulation contributes to hypertension. Targeting miRNAs offers a promising therapeutic strategy for managing this condition.
Area of Science:
- Molecular Biology
- Genetics
- Cardiovascular Research
Context:
- MicroRNAs (miRNAs) are crucial regulators of cellular functions like proliferation and apoptosis.
- Deregulation of miRNAs is linked to impaired cellular function and various diseases, including hypertension.
- Hypertension pathogenesis involves mechanisms such as renin-angiotensin-aldosterone system (RAAS) overactivation and vascular dysfunction.
Purpose:
- To review the role of miRNA in hypertension pathogenesis.
- To explore miRNAs as potential biomarkers for hypertension.
- To discuss miRNA-based therapeutic strategies for hypertension treatment.
Summary:
- This review examines the pathogenesis of microRNAs (miRNAs) in hypertension.
- It highlights research on miRNAs as biomarkers and therapeutic targets for hypertension.
- Advances in miRNA-based approaches for hypertension treatment are discussed.
Impact:
- Understanding miRNA's role in hypertension can lead to novel diagnostic tools.
- Targeting miRNAs may offer new therapeutic avenues for hypertension management.
- Stabilizing miRNA expression could be a key strategy in treating hypertension.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction

